HOME >> BIOLOGY >> NEWS
Leibniz Prize winners 2003

obtain twice the amount of photon energy at the intersection point of two coherent beams. This enables long-wave light to be used to achieve fluorescence effects which can otherwise only be produced with far greater energy, in other words shorter-wave light. This method offers advantages which can be exploited most importantly in the investigation of biological structures. It wasn't long before Winfried Denk was applying the advantages of the method he had developed to throw light on certain mysteries in the field of biology. Before long his area of interest was concentrated on the integration powers of nerve cells. Meanwhile, Winfried Denk has miniaturised his method to such an extent that it could soon become a realistic possibility to use it with free-moving animals. Entirely new approaches are emerging here for brain research.

Winfried Denk is currently a scientific member and Director of the Biomedical Optics Department of the Max Planck Institute for Medical Research in Heidelberg. He studied physics at the Ludwig-Maximilian University of Munich and the Swiss Federal Institute of Technology (ETH) in Zurich. He continued his studies at Cornell University in Ithaca, and then in 1989 he gained his doctorate in Professor W.W. Webb's laboratory. After a period of postdoctoral research in the IBM research laboratory in Rueshlikon he returned to the USA to a post at Bell Laboratories in Murray Hill, where he remained until he was offered a professorship at the Max Planck Society.

Prof. Dr. Hélène Esnault (49), algebraic geometry, Essen University, jointly with Prof. Dr. Eckart Viehweg (53), algebraic geometry, Essen University (1.55 million euros)

Hélène Esnault and Eckart Viehweg are the first married couple to be awarded the Leibniz Prize for scientific research carried out together. They have been working together for more than 20 years, and have produced around 25 substantial publications tog
'"/>

Contact: Ursula Rogmans-Beucher
ursula.rogmans-beucher@dfg.de
49-228-885-2726
Deutsche Forschungsgemeinschaft
3-Apr-2003


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Leibniz Prizewinners 2004
2. Prizes awarded in the 2002 Gottfried Wilhelm Leibniz Programme
3. Leibniz Prize Winners 1999 - Most Highly Endowed German Promotional Prize For Ten Scientists
4. Half-million dollar landmark achieved for the Methuselah Mouse Prize
5. Winner of 2004 EMBO Science Writing Prize announced
6. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
7. Stuart Lipton honored with Jung Prize for Medicine
8. 2004 Max Planck Research Prize for Martin Vingron and Eugene W. Myers
9. Scripps research scientist wins 2004 Koch Prize
10. Ohio State wetlands professor wins prestigious Water Prize
11. Tony Hunter and Raymond N. DuBois awarded Landon-AACR Prizes for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leibniz Prize winners

(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... , June 17, 2015 QIAGEN ... launched new Investigator ® STR assay kits for analysis ... United States . The new genetic fingerprint kits provide ... (short tandem repeats or STRs) for DNA matching. They incorporate ... of DNA in each sample, a novel QIAGEN technology that ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/2/2015)... PALO ALTO, Calif. (PRWEB) , ... July 02, 2015 , ... ... designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June ... and functionality: Luzi's voice command technology makes it effortless to use, while the integration ...
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
Breaking Biology Technology:Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
Cached News: